I
Immatics N.V.
Biotechnology: Biological Products (No Diagnostic Substances) company
Key Metrics of Immatics N.V.
Revenue—FY 2020
Operating income−€69.7M▲ 0.0% YoY
Net profit−€212M▲ 0.0% YoY
Shareholders' equity€87.4M
Market cap$1.1BIMTX · $7.31
Competitors10identified
About Immatics N.V.
Sectors
Company details
- Listed
- Nasdaq: IMTX
Operational Areas of Immatics N.V.
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameImmatics N.V.
TickerIMTX
ExchangeNasdaq
CountryGermany
SEC CIK0001809196
Listed since—
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
IMTX · Nasdaq · SEC CIK 0001809196
Last price · 30 Oct 2026
$7.31
−0.54%
Market cap$1.1B
P/E—On FY 2020 diluted EPS
Volume1,178,962
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOGermany
IMTX share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Immatics N.V.
Competitors10identified
Countries1most in Germany
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | the-odin.com | — | Solan, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | morphosys.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | curevac.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | medigene.com | — | Jaipur, Germany | |
 Evotec |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | evotec.com | 1993 | Germany |
| Part of GSK. | glaxosmithkline.de | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | miltenyibiotec.com | — | Hyderabad, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | mwg-biotech.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | promega.com | — | Mumbai, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gatc-biotech.com | — | Germany |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.